Cargando…

The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review

OBJECTIVE: To unveil the role of reactive oxygen species (ROS) and antioxidants in signaling and involvement in cancer progression and therapy. BACKGROUND: Cancer is considered one of the main causes of mortality in developed countries and expected to be more in developing countries as well. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekhet, Osama Hussein, Eid, Mohamed Elsayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799102/
https://www.ncbi.nlm.nih.gov/pubmed/35116715
http://dx.doi.org/10.21037/tcr-21-629
_version_ 1784641987192815616
author Bekhet, Osama Hussein
Eid, Mohamed Elsayed
author_facet Bekhet, Osama Hussein
Eid, Mohamed Elsayed
author_sort Bekhet, Osama Hussein
collection PubMed
description OBJECTIVE: To unveil the role of reactive oxygen species (ROS) and antioxidants in signaling and involvement in cancer progression and therapy. BACKGROUND: Cancer is considered one of the main causes of mortality in developed countries and expected to be more in developing countries as well. Although some cancers may develop at young age, yet almost all types of cancers are an accumulation of genetic and epigenetic cell damages. Cancer is considered a diverse collection of diseases on a cellular level rather than a single disease; and each disease has a different cause as well. ROS have been seen as harmful toxic molecules; however, they are recognized for cellular signaling capabilities. Elevated levels of ROS have protumorigenic activities; they induce cancer cell proliferation, and adaptation to hypoxia in addition to other effects like DNA damage and genetic instability. They are produced excessively by cancer cells to hyperactivate cellular transformation meanwhile increasing antioxidant capacity to avoid cell death. METHODS: We discussed peer reviewed published research work from 1987 to 2021. In this paper, we review the role of antioxidants as defensive barrier against excessive ROS levels for maintaining oxidation-reduction (redox) balance; however, antioxidant can also strive in tumor cells with their scavenging capacities and maintain protumorigenic signaling and resist the cancer cell oxidative stress and apoptosis. High doses of antioxidant compounds could be toxic to cells as they are capable of reacting with the physiological concentrations of ROS present for normal cellular processes and signaling. CONCLUSIONS: Maintaining cellular redox homeostasis is vital for healthy biological system. Therefore, therapeutic modalities for cancer including antioxidants and ROS management should be used at certain doses to target specific redox pathways involved in cancer progression without disrupting the overall redox balance in normal cells.
format Online
Article
Text
id pubmed-8799102
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87991022022-02-02 The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review Bekhet, Osama Hussein Eid, Mohamed Elsayed Transl Cancer Res Review Article OBJECTIVE: To unveil the role of reactive oxygen species (ROS) and antioxidants in signaling and involvement in cancer progression and therapy. BACKGROUND: Cancer is considered one of the main causes of mortality in developed countries and expected to be more in developing countries as well. Although some cancers may develop at young age, yet almost all types of cancers are an accumulation of genetic and epigenetic cell damages. Cancer is considered a diverse collection of diseases on a cellular level rather than a single disease; and each disease has a different cause as well. ROS have been seen as harmful toxic molecules; however, they are recognized for cellular signaling capabilities. Elevated levels of ROS have protumorigenic activities; they induce cancer cell proliferation, and adaptation to hypoxia in addition to other effects like DNA damage and genetic instability. They are produced excessively by cancer cells to hyperactivate cellular transformation meanwhile increasing antioxidant capacity to avoid cell death. METHODS: We discussed peer reviewed published research work from 1987 to 2021. In this paper, we review the role of antioxidants as defensive barrier against excessive ROS levels for maintaining oxidation-reduction (redox) balance; however, antioxidant can also strive in tumor cells with their scavenging capacities and maintain protumorigenic signaling and resist the cancer cell oxidative stress and apoptosis. High doses of antioxidant compounds could be toxic to cells as they are capable of reacting with the physiological concentrations of ROS present for normal cellular processes and signaling. CONCLUSIONS: Maintaining cellular redox homeostasis is vital for healthy biological system. Therefore, therapeutic modalities for cancer including antioxidants and ROS management should be used at certain doses to target specific redox pathways involved in cancer progression without disrupting the overall redox balance in normal cells. AME Publishing Company 2021-09 /pmc/articles/PMC8799102/ /pubmed/35116715 http://dx.doi.org/10.21037/tcr-21-629 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Review Article
Bekhet, Osama Hussein
Eid, Mohamed Elsayed
The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title_full The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title_fullStr The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title_full_unstemmed The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title_short The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
title_sort interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799102/
https://www.ncbi.nlm.nih.gov/pubmed/35116715
http://dx.doi.org/10.21037/tcr-21-629
work_keys_str_mv AT bekhetosamahussein theinterplaybetweenreactiveoxygenspeciesandantioxidantsincancerprogressionandtherapyanarrativereview
AT eidmohamedelsayed theinterplaybetweenreactiveoxygenspeciesandantioxidantsincancerprogressionandtherapyanarrativereview
AT bekhetosamahussein interplaybetweenreactiveoxygenspeciesandantioxidantsincancerprogressionandtherapyanarrativereview
AT eidmohamedelsayed interplaybetweenreactiveoxygenspeciesandantioxidantsincancerprogressionandtherapyanarrativereview